Dallas Fort Worth Injury Lawyer Blog

October 29, 2008

Texas Medical Board Suspends License of a Dallas Doctor

A panel of the Texas Medical Board suspended the license of Harold Clay Henderson, M.D., of Dallas, license number G3937, after determining that Dr. Henderson’s continuation in the practice of medicine presents a continuing threat to the public welfare.

The temporary suspension hearing took place Monday, October 27, under the Board’s authority, granted by S.B. 104 of the 78th Legislature, to suspend or restrict a physician’s license without notice when it determines the physician’s continuation in practice would constitute a continuing threat to the public welfare. The suspension is effective immediately.

The action was based on the panel’s finding of Dr. Henderson’s inability to safely practice medicine due to intemperate use of drugs or alcohol, or mental or physical disability. The panel also found that Dr. Henderson had aided and abetted the unlicensed practice of medicine by employing a physician in his office whose licensed was suspended.

October 29, 2008

BPA In Dental Sealants

by Dr. Shezad Malik

Parents are worried about a chemical substance found in the popular sealants that are painted on children’s molars to prevent decay.

The chemical is bisphenol-A, or BPA, which is widely used in the making of the hard, clear plastic called polycarbonate, and is also found in the linings of food and soft-drink cans. Most human exposure to the chemical clearly comes from the food supply. But traces have also been found in dental sealants.

Although the Food and Drug Administration (FDA) has reassured consumers that the chemical appears to be safe, it has received increasing scrutiny in recent months from health officials in the United States and Canada. See earlier post

October 28, 2008

Nevada and Narcotic Painkillers

by Dr. Shezad Malik

A Nevada doctor has been accused of causing the deaths of three patients and has numerous examples of alleged prescription drug malpractice.

Investigations of the doctor are on going, but the Nevada State Medical Examiners Board has not suspended his license or taken any steps to force him to curtail his prescribing of large quantities of narcotic painkillers.

The medical board has the authority to summarily suspend the license of a doctor who is putting patients in imminent harm.

October 27, 2008

Study Shows Problems with Medronic’s Heart Stent

by Dr. Shezad Malik

A new medical study out recently shows that Medtronic‘s new drug-coated stent was associated with more heart attacks and blood clots than a rival stent made by Johnson & Johnson.

Results from the cardiology study named Sort Out III, which included more than 2,000 patients, showed that heart patients who received the Medtronic device, called Endeavor, had more heart attacks and blood clots and needed repeat procedures more often than those treated with the J&J stent, known as Cypher.

October 26, 2008

Elevator Failure Led to Student’s Death

by Dr. Shezad Malik

A college freshman was killed in a dormitory elevator accident two years ago at Ohio State University.

Ohio State has taken safety measures, such as installing video cameras in all its high-rise elevators this year, in case someone gets trapped and as a way to help identify causes of mechanical malfunctions.

One other student (Morris) was in the elevator when the freshman was crushed between the ceiling of the elevator and the third-floor lobby. The fatally injured student was trying to get off the overloaded elevator when it unexpectedly descended with its doors open.

October 25, 2008

Ovarian Cancer Update

by Dr. Shezad Malik

Ovarian cancer is one of the most difficult cancers to diagnose, making it one of the most deadly. The ovaries are not accessible for examination, and the symptoms that are associated with ovarian cancer are vague and can be confused with other less life-threatening conditions.

Because of its hidden nature, ovarian cancer often is not caught in time to save the patient. According to the U.S. National Cancer Institute, three of every four ovarian cancer cases are diagnosed at an advanced stage, after the malignancy has spread beyond the ovary.

October 24, 2008

Pfizer to Settle Bextra and Celebrex Lawsuits

by Dr. Shezad Malik

Pfizer Inc. said it agreed earlier this week to pay $894 million to settle most Celebrex and Bextra claims.

Pfizer said in a statement that it is taking an after-tax charge of $640 million against profit in the quarter to cover the settlement sum.

Pfizer said it plans to settle most lawsuits involving the painkillers Bextra and Celebrex. The large size of the settlement heightens the pressure to cut costs, because Pfizer’s blockbuster cholesterol drug, Lipitor, is losing market share and sales growth of its once-promising antismoking drug, Chantix, has slowed because of safety concerns.

October 23, 2008

20 Drugs on FDA Watch List

by Dr. Shezad Malik

The FDA is “evaluating” new adverse-event reports for 20 drugs, the agency announced in September. A 2007 federal law requires the FDA to disclose all its investigations into reports of possibly drug-related adverse events.

The reports on the list come from the FDA’s early-warning system for drugs already on the market. This Adverse Event Reporting System (AERS) collects reports from patients, hospitals, doctors, and drug companies about suspicious problems that might be related to a medication.

October 22, 2008

Changes at the Texas Medical Board

by Dr. Shezad Malik

The Texas Medical Board has named Alan T. Moore, M.D., as interim medical director of the agency.

Dr. Moore graduated with honors from the University of Texas at Austin and received his medical degree from the U.T. Southwestern Medical School, where he was a member of Alpha Omega Alpha Honor Society. He completed his anatomic and clinical pathology residency at Parkland Memorial Hospital in Dallas, where he served as chief resident during his fourth year. He also completed a hematopathology fellowship at Parkland.

Dr. Moore is board certified in anatomic pathology, clinical pathology and hematopathology. He has practiced in Austin for more than 20 years and has served as president of Clinical Pathology Associates as well as on the board of Clinical Pathology Laboratories; medical director of Seton Medical Center Laboratory; chief of Staff at Seton Medical Center; and president of the Texas Society of Pathologists. He has also served as the transplant pathologist for the Seton Medical Center Cardiac Transplant Program.

October 22, 2008

New Rules Could Block Product Liability Suits

by Dr. Shezad Malik

WASHINGTON — The Bush administration is planning to rewrite a wide array of federal rules with changes or additions that could block product-safety lawsuits by consumers and states.

The administration has written language aimed at pre-empting product-liability litigation into 50 rules governing everything from motorcycle brakes to pain medicine. This year, lawsuit-protection language has been added to 10 new regulations, including one issued Oct. 8 at the Department of Transportation that limits the number of seatbelts car makers can be forced to install and prohibits suits by injured passengers who did not get to wear one.